- Trials with a EudraCT protocol (6,408)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (10,738)
6,408 result(s) found.
Displaying page 1 of 321.
EudraCT Number: 2016-004462-26 | Sponsor Protocol Number: VBP15-002 | Start Date*: 2017-02-16 | |||||||||||
Sponsor Name:ReveraGen BioPharma, Inc. | |||||||||||||
Full Title: VBP15-002 A Phase IIa Open-Label, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Vamorolone in Boys with Duchenne ... | |||||||||||||
Medical condition: Duchenne muscular dystrophy (DMD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001823-39 | Sponsor Protocol Number: 103502 | Start Date*: 2004-11-15 |
Sponsor Name:GlaxoSmithKline Biologicals | ||
Full Title: An open, randomized, controlled, phase II study to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals’ 11-valent pneumococcal conjugate vaccine, when administered intramuscularly... | ||
Medical condition: Prophylactic vaccination against pneumococcal diseases in infants and diseases caused by Neisseria meningitidis C. | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-000751-42 | Sponsor Protocol Number: D1441C00150 | Start Date*: 2006-04-07 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A 26-week, International, Multicenter, Open-label Phase IIIb Study of the Safety and Tolerability of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets in Daily Doses of 400 mg to 800 mg in ... | ||
Medical condition: SCHIZOPHRENIA or BIPOLAR I DISORDER | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002802-31 | Sponsor Protocol Number: PENT-IBD-CH CZ | Start Date*: 2005-01-25 |
Sponsor Name:Ferring-Leciva, a.s. | ||
Full Title: Multicentre, Controlled, Randomised, Open, Cross-over Study Comparing the Acceptability of Pentasa® Sachets versus Pentasa® tbl. 500mg in Children with Crohn´s Disease | ||
Medical condition: children patients with the Crohn s disease in any stage (where mesalazine treatment is appropriate) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2004-001653-28 | Sponsor Protocol Number: 03/314 | Start Date*: Information not available in EudraCT |
Sponsor Name:The Leeds teaching Hospitals NHS trust | ||
Full Title: A comparison of the effects on prostaglandin synthesis and cytokine production of an olive-oil based lipid emulsion (Clinoloeic) with a soya based emulsion (Intralipid) in newborn infnats receiving... | ||
Medical condition: Prematurity Parenteral nutrition | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002669-19 | Sponsor Protocol Number: X04-VAR-402 | Start Date*: 2004-12-23 | |||||||||||
Sponsor Name:AVENTIS PASTEUR MSD S.P.A. | |||||||||||||
Full Title: A double-blind, randomised, controlled, multi-centre safety study of a refrigerator-stable formulation of VARIVAX® in healthy 12 to 15 month-old infants. | |||||||||||||
Medical condition: Active immunisation against varicella | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000006-32 | Sponsor Protocol Number: IXR-203-30-204 | Start Date*: 2005-06-13 |
Sponsor Name:IVAX RESEARCH, INC. | ||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, DOSE RANGING STUDY TO DETERMINE THE EFFICACY AND SAFETY OF AN INVESTIGATIONAL INTRANASAL CORTICOSTEROID COMPARED TO PLACEBO AND OPEN-LABEL FLUTICASONE PR... | ||
Medical condition: Perennial (persistant) Allergic Rhinitis | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: SK (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001738-17 | Sponsor Protocol Number: GIMEMALAL0904 | Start Date*: 2004-11-08 | |||||||||||
Sponsor Name:G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO | |||||||||||||
Full Title: Evaluation of the intensification of post-remissional therapy in the treatment of high-risks adult Acute Lymphoblastic Leukemia and monitoring of the minimal residual disease | |||||||||||||
Medical condition: Patients with T- and B-ALL; Age >14 and <61 years | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001952-35 | Sponsor Protocol Number: M71P1 | Start Date*: 2005-09-15 |
Sponsor Name:Chiron S.r.l. | ||
Full Title: A Phase IV, Observer-Blind, Randomized, Parallel Groups, Single-Center, Exploratory Clinical Study to Evaluate the Immunogenicity and Safety of Two 0.25 mL Intramuscular Doses of Agrippal™ S1, Infl... | ||
Medical condition: Influenza | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2004-002586-21 | Sponsor Protocol Number: X04-MMRr-301 | Start Date*: 2004-12-23 |
Sponsor Name:Aventis Pasteur MSD SNC | ||
Full Title: An open, randomised, comparative, multicentre study of the immunogenicity and safety of M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX® when administered concomitantly by in... | ||
Medical condition: Not applicable - Healthy subjects | ||
Disease: | ||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-001909-25 | Sponsor Protocol Number: | Start Date*: Information not available in EudraCT |
Sponsor Name: | ||
Full Title: Effekter av behandling med atomoxetine ved komorbid ADHD hos pasienter med Pervasive Developmental Disorders (Effects of treatment with atomoxetine in children with Pervasive Developmental Disorder... | ||
Medical condition: Open treatment with atomoxetine for 10 weeks: •Week 1: 0,5 mg/kg/day in 1 or 2 doses. •Week 2 – 6: 1,2 mg/kg/day i 1 or 2 doses. •Week 6 – 8: Significant improvements: Continue on 1,2 mg/kg/day in ... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000704-14 | Sponsor Protocol Number: S241-GB-07 | Start Date*: Information not available in EudraCT |
Sponsor Name:Stiefel Laboratories International Division | ||
Full Title: Human 96 Hour Repeat Open Application Test for Assessment of Skin Irritation | ||
Medical condition: Not applicable (Healthy Volunteer Study) | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2004-002137-39 | Sponsor Protocol Number: V1 25/07/04 | Start Date*: 2004-09-17 |
Sponsor Name: | ||
Full Title: A randomised controlled trial of the combined use of paracetamol and ibuprofen to treat febrile children | ||
Medical condition: Fevers in childhood not asscoaited with severe disease in the immunocompenetent or fever in the immunocompromised host. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002136-10 | Sponsor Protocol Number: GRIFO-A | Start Date*: 2005-07-08 | |||||||||||
Sponsor Name:ISTITUTO GIANNINA GASLINI | |||||||||||||
Full Title: Comparison between once-per-cycle peg-Filgrastim and daily injection r-Hu-G-CSF in chemotherapy-induced neutropenia treatment and peripheral blood progenitor cells mobilization in childhood. | |||||||||||||
Medical condition: chemotherapy-induced neutropenia treatment peripheral blood progenitor cells mobilization | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004342-41 | Sponsor Protocol Number: LAM100034 | Start Date*: 2005-04-28 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: A Multicenter, Double-Blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-release Adjunctive Therapy in Subjects with Partial Seizures | ||
Medical condition: Epilepsy -partial seizures | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002404-42 | Sponsor Protocol Number: 17465 | Start Date*: 2005-08-18 |
Sponsor Name:University of Dundee | ||
Full Title: A pilot study to inform a randomised controlled trial of iodine supplementation in preterm infants | ||
Medical condition: transient hypothyroxinaemia | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-003059-56 | Sponsor Protocol Number: ICAND | Start Date*: 2008-07-29 | |||||||||||
Sponsor Name:ISTITUTO NEUROLOGICO "CARLO BESTA" | |||||||||||||
Full Title: Phase II trial to assess safety and efficacy of Iron chelating agent Deferiprone in patients with Pantothenate Kinase-Associated Neurodegeneration ICAND Trial | |||||||||||||
Medical condition: PKAN | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003402-29 | Sponsor Protocol Number: vitA | Start Date*: 2005-10-21 |
Sponsor Name:Greater Glasgow NHS Board, Yorkhill Division | ||
Full Title: Does additional vitamin A supplementation improve retinal function and conjunctival health in very low birth weight infants? | ||
Medical condition: Presumed vitamin A deficiency in preterm infants | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002585-11 | Sponsor Protocol Number: AL001 | Start Date*: 2005-10-10 |
Sponsor Name:Imperial College | ||
Full Title: CPAP;Heliox Effects on Stability and Therapeutics | ||
Medical condition: Respiratory Distress requiring CPAP Examples: Bronchilitis, post-exturbation, Upper Airway Obstruction... | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-003007-36 | Sponsor Protocol Number: HP002A | Start Date*: 2006-08-02 | |||||||||||
Sponsor Name:Imperial College London [...] | |||||||||||||
Full Title: B.R.E.A.T.H.E. Bronchiolitis RCT: Emergency Assisted Therapy with Heliox - an Evaluation. A Prospective, Double-Blinded, Randomised, Controlled Clinical Trial to assess the effect of helium-oxygen ... | |||||||||||||
Medical condition: Bronchiolitis | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
